VERTEX PHARMACEUTICALS INC / MA Senior Notes, Noncurrent
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Senior Notes, Noncurrent of $0 as of 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:SeniorLongTermNotes · last filed 2017-02-23
- 2016-12-31: Senior Notes, Noncurrent $0.00.
- 2016-09-30: Senior Notes, Noncurrent $0.00.
- 2016-06-30: Senior Notes, Noncurrent $74.92M.
- 2016-03-31: Senior Notes, Noncurrent $149.57M.
| Period end | Senior Notes, Noncurrent | Senior Notes, Noncurrent as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-23 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $74.92M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $149.57M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $223.86M 10-K · filed 2017-02-23 | $223.97M 10-K · filed 2016-02-16 |
| 2015-09-30 | $294.83M 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $251.94M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $266.27M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $280.57M 10-K · filed 2016-02-16 | |
| 2014-09-30 | $294.74M 10-Q · filed 2014-11-06 | |
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |